Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different Doses of Roxadustat in Peritoneal Dialysis
NCT04454879Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of roxadustat in anemia of chronic kidney disease (2 arms), sponsored by Peking University First Hospital. Primary endpoint: The ratio of hemoglobin achieving the target (115g/L) at 12 weeks. Started Jul 2020; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT04454879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454879.